Knockdown of tissue transglutaminase in SaOS-2 cell line inhibits its osteoblastic differentiation and mineralization
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [20]
  • | | | |
  • Comments
    Abstract:

    Objective To investigate whether TG2 plays an important role in the osteoblast differentiation and mineralization. Methods TG2 mRNA of SaOS-2 cells was knocked down using a lentivirus stably expressing short-hairpin(sh) RNA targeting TG2.Then the cells were cultured in osteo-inductive medium for 14 d to measure mineralization and for 7 d to measure the levels of osteoblastic differentiation markers including ALP activity and mRNA of collagen I, osteocalcin(OCN) and BMP-2.The wild-type SaOS-2 cells and scrambled shRNA-transducted SaOS-2 cells served as the controls. Results The controls displayed an increasing trend of the level of ALP activity and mRNA of collagen I, osteocalcin and BMP-2,and notable mineralization at 14 d.When TG2 was knocked down, ALP activity, mRNA of collagen I, osteocalcin and BMP-2 at 7d,and mineralization at 14 d were all significantly lower in comparison with the corresponding values in the controls.Conclusion TG2 is involved in the differentiation and mineralization of osteoblasts in vitro.

    Reference
    [1] Nurminskaya MV, Belkin AM. Cellular functions of tissue transglutaminase. In: Jeon Kw Ed.Int Rev Cell Mol Biol,2012,294:1-97.
    [2] Kaartinen MT, El-maadawy S, Rasanen NH, et al. Tissue transglutaminase and its substrates in bone [J]. J Bone Mineral Res. 2002, 17(12):2161-2173.
    [3] Kaartinen MT, Sun W, Kaipatur N, et al. Transglutaminase crosslinking of sibling proteins in teeth [J]. J Dental Res, 2005, 84(7):607-612.
    [4] Nurminskaya M, Kaartinen MT. Transglutaminases in mineralized tissues [J]. Front Biosci, 2006, 11: 1591-1606.
    [5] Nurminsky D, Shanmugasundaram S, Deasey S, et al. Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis [J]. Mech Dev, 2011, 128(3-4):234-245.
    [6] Al-jallad HF, Nakano Y, Chen JL, et al. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in mc3t3-e1 osteoblast cultures [J]. Matrix Biol, 2006, 25(3):135-148.
    [7] Deasey S, Grichenko O, Du S, et al. Characterization of the transglutaminase gene family in zebrafish and in vivo analysis of transglutaminase-dependent bone mineralization [j]. Amino Acids, 2012, 42(2-3):1065-1075.
    [8] Watanabe K, Tsunoda K, Itoh M, et al. Transglutaminase 2 and factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides [J]. Amino Acids, 2013, 44(1):209-214.
    [9] Beazley KE, Deasey S, Lima F, et al. transglutaminase 2-mediated activation of beta-catenin signaling has a critical role in warfarin-induced vascular calcification [J]. Arteriosc Thromb Vasc Biol, 2012, 32(1):123-u302.
    [10] Yin XX, Chen ZQ, Guo ZQ, et al. Tissue transglutaminase expression and activity in human ligamentum flavum cells derived from thoracic ossification of ligamentum flavum [J]. Spine, 2010, 35(20):e1018-e1024.
    [11] Johnson KA, Polewski M, Terkeltaub RA. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells [J]. Circ Res, 2008, 102(5):529-537.
    [12] Al-jallad HF, Myneni VD, Piercy-kotb SA, et al. Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics [J]. Plos One, 2011, 6(1): e1589.
    [13] Yin XX, Chen ZQ, Liu ZJ, et al. Tissue transglutaminase (tg2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line [J]. Braz J Med Biol Res, 2012, 45(8):693-700.
    [14] Prideaux M, Wijenayaka AR, Kumarasinghe DD, et al. SSOS2 osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes [J]. Calc Tissue Int, 2014, 95(2):183-193.
    [15] Cordell PA, Newell LM, Standeven KF, et al. Normal bone deposition occurs in mice deficient in factor XIII-a and transglutaminase 2 [J]. Matrix Biol, 2015, 43: 85-96.
    [16] Rossi A, Kontarakis Z, Gerri C, et al. genetic compensation induced by deleterious mutations but not gene knockdowns [J]. Nature, 2015, 524(7564):230-233.
    [17] Marsh ME, Munne AM, Vogel JJ, et al. Mineralization of bone-like extracellular-matrix in the absence of functional osteoblasts [J]. J Bone Mineral Res, 1995, 10(11):1635-1643.
    [18] Fortunati D, Chau DY, Wang Z, et al. Cross-linking of collagen I by tissue transglutaminase provides a promising biomaterial for promoting bone healing [J]. Amino Acids, 2014, 46(7):1751-1761.
    [19] Rahman MS, Akhtar N, Jamil HM, et al. Tgf-beta/bmp signaling and other molecular events: regulation of osteoblastogenesis and bone formation [J]. Bone Res, 2015, 3:15005.
    [20] Lismaa SE, Mearns BM, Lorand I, et al. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders [J]. Physiol Rev, 2009, 89(3):991-1023.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 08,2016
  • Online: November 02,2016
Article QR Code